Paper
Cannabis use in HIV for pain and other medical symptoms.
Published Apr 1, 2005 · Emily Woolridge, S. Barton, J. Samuel
Journal of pain and symptom management
Q1 SJR score
201
Citations
14
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Highly CitedStudy Snapshot
Key takeawayCannabis use in HIV patients is widespread, improving appetite, muscle pain, nausea, anxiety, nerve pain, depression, and paresthesia, with some memory deterioration.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Cannabinoids, specifically CB1 agonists, may slow neurodegeneration and slow chronic disability in multiple sclerosis and other diseases.
2003·348citations·G. Pryce et al.·Brain : a journal of neurology
Brain : a journal of neurology
The endocannabinoid system and Huntington's disease.
Cannabinoids show potential in treating Huntington's disease by acting on CB1 receptors, which may delay or arrest its development by addressing hypofunctionality in the endocannabinoid system.
2003·55citations·I. Lastres-Becker et al.·Current drug targets. CNS and neurological disorders
Current drug targets. CNS and neurological disorders
Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection
Cannabinoids, such as marijuana and dronabinol, show small, short-term effects on viral loads in HIV-infected patients taking protease inhibitors, with no large harmful effects observed.
2003·154citations·D. Abrams et al.·Annals of Internal Medicine
Annals of Internal Medicine
Cannabis and the brain.
Cannabis' central effects include disruption of psychomotor behavior, short-term memory impairment, intoxication, stimulation of appetite, antinociceptive actions, and potential medical applications in treating multiple sclerosis symptoms.
2003·754citations·L. Iversen·Brain : a journal of neurology
Brain : a journal of neurology
Cannabis use for chronic non-cancer pain: results of a prospective survey
Cannabis use is prevalent among chronic non-cancer pain patients, with varying amounts and frequency, improving pain, sleep, and mood, but also causing side effects and potential interactions with other medications.
2003·170citations·M. Ware et al.·Pain
Pain
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
Cannabis medicinal extracts can improve neurogenic symptoms unresponsive to standard treatments, with predictable and generally well-tolerated adverse effects.
2003·436citations·D. Wade et al.·Clinical Rehabilitation
Clinical Rehabilitation
Non-nucleoside reverse transcriptase inhibitors—an overview
Efavirenz is highly effective and well-tolerated in combination with nucleosides stavudine and lamivudine for treating HIV in patients with low CD4 cell counts.
2003·13citations·C. Bell et al.·International Journal of STD & AIDS
International Journal of STD & AIDS
HIV-associated sensory neuropathies
HIV-associated neuropathies can be classified based on their timing, etiology, and primarily axonal or demyelinating nature, with some occurring as a result of HIV infection, others from opportunistic pathogens, and others from treatment toxicity.
2002·223citations·Sanjay C. Keswani et al.·AIDS
AIDS
Citations
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
CBD and THC use in special populations raises the risk of drug-drug interactions, but current studies are inadequate and modeling approaches can help understand these interactions.
2024·1citation·Lixuan Qian et al.·Pharmaceutics
Pharmaceutics
Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study
Persons with HIV who report using cannabis or opioids are more likely to report moderate/severe pain compared to those who do not use these substances.
2024·0citations·H. J. Kim et al.·Medicine
Medicine
Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
Acute CBD has no to minimal effects on behavior and the endocannabinoid system in HIV Tat transgenic mice, suggesting it has no altering effects on HIV symptoms.
2024·1citation·Barkha J. Yadav-Samudrala et al.·Frontiers in Neuroscience
Frontiers in Neuroscience
Top Ten Tips Palliative Care Clinicians Should Know About Integrative Palliative Care.
Integrative palliative care (IPC) enhances quality of life for patients with serious illness by combining standard-of-care biomedical treatments with evidence-informed integrative and complementary medicine practices.
2023·1citation·Brieze K Bell et al.·Journal of palliative medicine
Journal of palliative medicine
Self-medication of pain and discomfort with alcohol and other substances by people with HIV infection and substance use disorder: preliminary findings from a secondary analysis
Self-medication with alcohol and other substances is highly prevalent among people with HIV and substance use disorders, and is associated with worse mental health symptoms, greater substance use, and lesser HIV disease control.
2023·1citation·Michael D. Stein et al.·AIDS Care
AIDS Care
Perceived risks and benefits and frequency of cannabis use among people with HIV in different legal environments.
Legalization of cannabis did not affect the frequency of use in people living with HIV, but daily users are more likely to identify benefits and less likely to identify risks compared to yearly or never users.
2023·0citations·Sarah Laper et al.·AIDS research and human retroviruses
AIDS research and human retroviruses